Stay updated on CC-486 and Venetoclax for AML Clinical Trial
Sign up to get notified when there's something new on the CC-486 and Venetoclax for AML Clinical Trial page.

Latest updates to the CC-486 and Venetoclax for AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check44 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check59 days agoChange DetectedThe website has been updated from version v2.14.0 to v2.14.1.SummaryDifference0.3%
- Check66 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check73 days agoChange DetectedA new addition was made on January 3, 2025, while a deletion occurred on May 16, 2024.SummaryDifference1.0%
Stay in the know with updates to CC-486 and Venetoclax for AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-486 and Venetoclax for AML Clinical Trial page.